Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Aclaris Therapeutics, Inc. (ACRS) had Book Value Per Share of $0.86 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.29M |
|
$-19.80M |
|
$1.47M |
|
$-0.17M |
|
$24.03M |
|
$-22.73M |
|
$2.94M |
|
$-19.80M |
|
$-19.80M |
|
$-19.80M |
|
$-19.80M |
|
$-19.80M |
|
$-19.80M |
|
$-22.73M |
|
$-22.63M |
|
122.56M |
|
122.56M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$96.32M |
|
$0.76M |
|
$64.14M |
|
$160.46M |
|
$28.64M |
|
-- |
|
$28.73M |
|
$57.38M |
|
$103.08M |
|
$103.08M |
|
$103.08M |
|
120.50M |
|
| Cash Flow Statement Financials | |
$-47.11M |
|
$48.37M |
|
$-5.86M |
|
$24.57M |
|
$19.96M |
|
$-4.61M |
|
$12.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.44% |
|
-1755.52% |
|
-1755.52% |
|
-- |
|
-1528.57% |
|
-1528.57% |
|
$-47.22M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.23 |
|
386.76 |
|
-19.20% |
|
-19.20% |
|
-12.34% |
|
-19.20% |
|
|
Book Value Per Share |
$0.86 |
$-0.39 |
|
$-0.38 |
|